Weill Cornell Medical College-NY Presbyterian Hospital
Welcome,         Profile    Billing    Logout  
 3 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Niesvizky, Ruben
NCT01559935: Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma

Active, not recruiting
2
74
US
carfilzomib, Dexamethasone, DECADRON®, Clarithromycin, Biaxin, Lenalidomide, Revlimid
Weill Medical College of Cornell University, Onyx Therapeutics, Inc.
Multiple Myeloma
06/16
03/26
NCT05427812: Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma

Recruiting
1/2
121
US, RoW
ISB 1442 SC injection escalating doses, ISB 1442 SC injection at RP2D
Ichnos Sciences SA
Relapsed/Refractory Multiple Myeloma
05/27
05/27
SET-101, NCT05121103: A Study of the Safety, Tolerability and Effectiveness of EZM0414 Investigative Product in Participants With Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B Cell Lymphoma

Terminated
1
13
US
EZM0414
Epizyme, Inc.
Multiple Myeloma, Refractory, Diffuse Large B-Cell Lymphoma, Diffuse Large B Cell Lymphoma Refractory, Multiple Myeloma in Relapse
04/24
04/24
SGNBCMA-001, NCT03582033: A Safety Study of SEA-BCMA in Patients With Multiple Myeloma

Terminated
1
83
US
SEA-BCMA, dexamethasone, pomalidomide
Seagen Inc.
Multiple Myeloma
11/23
11/23
DREAMM 12, NCT04398745: A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function

Recruiting
1
36
Europe, US, RoW
Belantamab mafodotin, GSK2857916
GlaxoSmithKline
Multiple Myeloma
02/25
02/25
iinnovate-2, NCT05556616: A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma

Completed
1
15
Europe, US, RoW
Modakafusp alfa, TAK-573, Lenalidomide, Bortezomib, Carfilzomib, Daratumumab, Pomalidomide
Takeda
Multiple Myeloma
01/24
06/24

Download Options